Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Belgium Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20111
20121
20131
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company4
Immunovant Sciences GmbH2
AstraZeneca1
GlaxoSmithKline1
Human Genome Sciences Inc.1
Janssen Biotech, Inc.1
Pfizer1
X4 Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases12
Lupus Erythematosus, Systemic4
Arthritis, Rheumatoid2
Graves Ophthalmopathy2
Lung Diseases, Interstitial2
Arthritis1
Barth Syndrome1
Connective Tissue Diseases1
Glomerulonephritis1
Granulomatosis with Polyangiitis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.